BIIB logo

Biogen Inc. (BIIB) Cash From Investing

Annual CFI:

-$799.20M+$3.29B(+80.45%)
December 31, 2024

Summary

  • As of today, BIIB annual cash from investing is -$799.20 million, with the most recent change of +$3.29 billion (+80.45%) on December 31, 2024.
  • During the last 3 years, BIIB annual cash from investing has fallen by -$235.50 million (-41.78%).
  • BIIB annual cash from investing is now -150.30% below its all-time high of $1.59 billion, reached on December 31, 2022.

Performance

BIIB Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Quarterly CFI:

-$35.10M+$21.90M(+38.42%)
September 30, 2025

Summary

  • As of today, BIIB quarterly cash from investing is -$35.10 million, with the most recent change of +$21.90 million (+38.42%) on September 30, 2025.
  • Over the past year, BIIB quarterly cash from investing has increased by +$1.15 billion (+97.03%).
  • BIIB quarterly cash from investing is now -102.08% below its all-time high of $1.68 billion, reached on September 30, 2022.

Performance

BIIB Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFI:

-$158.00M+$1.15B(+87.88%)
September 30, 2025

Summary

  • As of today, BIIB TTM cash from investing is -$158.00 million, with the most recent change of +$1.15 billion (+87.88%) on September 30, 2025.
  • Over the past year, BIIB TTM cash from investing has increased by +$1.27 billion (+88.91%).
  • BIIB TTM cash from investing is now -109.77% below its all-time high of $1.62 billion, reached on September 30, 2022.

Performance

BIIB TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BIIB Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+80.5%+97.0%+88.9%
3Y3 Years-41.8%-102.1%-109.8%
5Y5 Years-+33.0%-159.3%

BIIB Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-150.3%+80.5%-102.1%+98.0%-109.8%+96.1%
5Y5-Year-150.3%+80.5%-102.1%+98.0%-109.8%+96.1%
All-TimeAll-Time-150.3%+82.5%-102.1%+98.0%-109.8%+96.1%

BIIB Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$35.10M(+38.4%)
-$158.00M(+87.9%)
Jun 2025
-
-$57.00M(-20.5%)
-$1.30B(-67.1%)
Mar 2025
-
-$47.30M(-154.3%)
-$780.50M(+2.3%)
Dec 2024
-$799.20M(+80.5%)
-$18.60M(+98.4%)
-$799.20M(+43.9%)
Sep 2024
-
-$1.18B(-353.2%)
-$1.42B(+28.2%)
Jun 2024
-
$466.50M(+806.8%)
-$1.98B(+38.1%)
Mar 2024
-
-$66.00M(+89.8%)
-$3.20B(+21.7%)
Dec 2023
-$4.09B(-357.3%)
-$644.20M(+63.0%)
-$4.09B(-14.0%)
Sep 2023
-
-$1.74B(-131.3%)
-$3.59B(-2122.8%)
Jun 2023
-
-$752.00M(+21.1%)
-$161.30M(-112.6%)
Mar 2023
-
-$952.80M(-576.2%)
$1.28B(-19.2%)
Dec 2022
$1.59B(+381.9%)
-$140.90M(-108.4%)
$1.59B(-1.7%)
Sep 2022
-
$1.68B(+142.9%)
$1.62B(+637.6%)
Jun 2022
-
$693.50M(+207.0%)
-$300.80M(+73.8%)
Mar 2022
-
-$648.00M(-475.0%)
-$1.15B(-103.5%)
Dec 2021
-$563.70M(+7.4%)
-$112.70M(+51.8%)
-$563.70M(+8.7%)
Sep 2021
-
-$233.60M(-53.0%)
-$617.40M(-41.5%)
Jun 2021
-
-$152.70M(-136.0%)
-$436.20M(+60.9%)
Mar 2021
-
-$64.70M(+61.1%)
-$1.12B(-83.4%)
Dec 2020
-$608.60M(+70.3%)
-$166.40M(-217.6%)
-$608.60M(-328.6%)
Sep 2020
-
-$52.40M(+93.7%)
$266.20M(+662.8%)
Jun 2020
-
-$832.70M(-288.0%)
-$47.30M(-107.0%)
Mar 2020
-
$442.90M(-37.5%)
$674.60M(+43.4%)
Dec 2019
-
$708.40M(+293.6%)
$470.50M(+125.3%)
Sep 2019
-
-$365.90M(-230.2%)
-$1.86B(+12.0%)
Jun 2019
-
-$110.80M(-146.4%)
-$2.12B(+32.9%)
Mar 2019
-
$238.80M(+114.7%)
-$3.15B(-54.1%)
Dec 2018
-$2.05B(+30.9%)
-$1.63B(-162.5%)
-$2.05B(-71.9%)
Sep 2018
-
-$619.10M(+46.1%)
-$1.19B(+34.5%)
Jun 2018
-
-$1.15B(-185.3%)
-$1.82B(-108.4%)
Mar 2018
-
$1.35B(+275.0%)
-$872.30M(+70.6%)
Dec 2017
-$2.96B(-19.2%)
-$769.50M(+38.3%)
-$2.96B(-6.8%)
Sep 2017
-
-$1.25B(-515.4%)
-$2.78B(-86.0%)
Jun 2017
-
-$202.60M(+72.8%)
-$1.49B(+26.3%)
Mar 2017
-
-$744.20M(-27.9%)
-$2.03B(+18.5%)
Dec 2016
-$2.48B(+45.4%)
-$581.70M(-1706.9%)
-$2.48B(-30.6%)
Sep 2016
-
$36.20M(+104.9%)
-$1.90B(+35.0%)
Jun 2016
-
-$736.10M(+38.8%)
-$2.93B(+15.0%)
Mar 2016
-
-$1.20B(-21.5%)
-$3.45B(-10.3%)
Dec 2015
-$4.55B(-195.1%)
-
-
Sep 2015
-
-$989.94M(+21.0%)
-$3.12B(-16.8%)
Jun 2015
-
-$1.25B(-149.3%)
-$2.67B(-30.4%)
Mar 2015
-
-$502.77M(-32.9%)
-$2.05B(-33.0%)
Dec 2014
-$1.54B(+3.8%)
-$378.28M(+30.0%)
-$1.54B(+17.7%)
Sep 2014
-
-$540.56M(+14.2%)
-$1.87B(-13.0%)
Jun 2014
-
-$630.13M(>-9900.0%)
-$1.66B(+5.5%)
Mar 2014
-
$5.99M(+100.8%)
-$1.75B(-9.3%)
Dec 2013
-$1.60B(-68.9%)
-$709.98M(-118.9%)
-$1.60B(-26.3%)
Sep 2013
-
-$324.39M(+55.3%)
-$1.27B(+13.5%)
Jun 2013
-
-$726.24M(-565.7%)
-$1.47B(-84.7%)
Mar 2013
-
$155.94M(+141.5%)
-$795.02M(+16.3%)
Dec 2012
-$950.34M(+42.4%)
-$375.45M(+28.1%)
-$950.34M(+1.5%)
Sep 2012
-
-$522.39M(-883.5%)
-$964.42M(+6.3%)
Jun 2012
-
-$53.12M(-8694.8%)
-$1.03B(+32.4%)
Mar 2012
-
$618.00K(+100.2%)
-$1.52B(+7.7%)
Dec 2011
-$1.65B(-577.9%)
-$389.53M(+33.7%)
-$1.65B(+7.3%)
Sep 2011
-
-$587.18M(-7.4%)
-$1.78B(-41.0%)
Jun 2011
-
-$546.79M(-331.2%)
-$1.26B(-3943.8%)
Mar 2011
-
-$126.80M(+75.6%)
-$31.21M(-109.0%)
Dec 2010
$345.32M(+187.4%)
-$518.62M(-643.5%)
$345.32M(-72.3%)
Sep 2010
-
-$69.75M(-110.2%)
$1.25B(+48.1%)
Jun 2010
-
$683.96M(+173.9%)
$841.89M(+1671.0%)
Mar 2010
-
$249.74M(-34.7%)
-$53.59M(+86.4%)
Dec 2009
-$395.03M(-8.0%)
$382.62M(+180.6%)
-$395.03M(+68.2%)
Sep 2009
-
-$474.43M(-124.3%)
-$1.24B(-43.2%)
Jun 2009
-
-$211.51M(-130.6%)
-$868.45M(+4.3%)
Mar 2009
-
-$91.71M(+80.3%)
-$907.16M(-147.9%)
Dec 2008
-$365.87M(-27.7%)
-$465.76M(-368.2%)
-$365.87M(+29.2%)
Sep 2008
-
-$99.47M(+60.2%)
-$516.75M(-6.8%)
Jun 2008
-
-$250.22M(-155.7%)
-$483.93M(-246.5%)
Mar 2008
-
$449.58M(+172.9%)
$330.39M(+215.3%)
Dec 2007
-$286.57M
-$616.63M(-825.2%)
-$286.57M(-207.6%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$66.65M(-111.8%)
$266.38M(-41.4%)
Jun 2007
-
$564.09M(+437.0%)
$454.52M(+191.8%)
Mar 2007
-
-$167.38M(-162.9%)
-$494.94M(+17.5%)
Dec 2006
-
-$63.68M(-152.4%)
-$599.77M(+1.2%)
Sep 2006
-
$121.49M(+131.5%)
-$607.04M(+51.9%)
Jun 2006
-
-$385.37M(-41.6%)
-$1.26B(-940.5%)
Mar 2006
-
-$272.21M(-283.7%)
$150.24M(-64.0%)
Dec 2005
$417.74M(+209.2%)
-$70.94M(+86.7%)
$417.74M(+44.6%)
Sep 2005
-
-$534.29M(-152.0%)
$288.89M(-56.0%)
Jun 2005
-
$1.03B(>+9900.0%)
$657.26M(+1022.7%)
Mar 2005
-
-$4.71M(+97.6%)
-$71.23M(+81.4%)
Dec 2004
-$382.43M(-37.1%)
-$199.79M(-20.4%)
-$382.43M(-41.4%)
Sep 2004
-
-$165.93M(-155.5%)
-$270.44M(-129.1%)
Jun 2004
-
$299.20M(+194.7%)
-$118.07M(+76.4%)
Mar 2004
-
-$315.91M(-259.8%)
-$500.50M(-79.4%)
Dec 2003
-$278.93M(+66.8%)
-$87.80M(-547.5%)
-$278.93M(+11.8%)
Sep 2003
-
-$13.56M(+83.7%)
-$316.42M(+40.9%)
Jun 2003
-
-$83.23M(+11.8%)
-$535.67M(+37.7%)
Mar 2003
-
-$94.34M(+24.7%)
-$859.34M(-2.4%)
Dec 2002
-$839.15M(-437.2%)
-$125.29M(+46.2%)
-$839.15M(-7.1%)
Sep 2002
-
-$232.81M(+42.8%)
-$783.33M(-29.8%)
Jun 2002
-
-$406.89M(-448.7%)
-$603.36M(-191.9%)
Mar 2002
-
-$74.16M(-6.8%)
-$206.67M(-32.3%)
Dec 2001
-$156.22M(+19.9%)
-$69.47M(-31.5%)
-$156.22M(+40.0%)
Sep 2001
-
-$52.84M(-418.3%)
-$260.42M(-5.6%)
Jun 2001
-
-$10.20M(+57.0%)
-$246.54M(-10.3%)
Mar 2001
-
-$23.71M(+86.3%)
-$223.43M(-14.6%)
Dec 2000
-$194.96M(-36.2%)
-$173.66M(-345.7%)
-$194.96M(-248.2%)
Sep 2000
-
-$38.96M(-401.7%)
-$55.99M(-122.2%)
Jun 2000
-
$12.91M(+171.9%)
-$25.20M(+71.7%)
Mar 2000
-
$4.75M(+113.7%)
-$88.94M(+37.9%)
Dec 1999
-$143.14M(-1559.0%)
-$34.69M(-324.4%)
-$143.14M(-30.9%)
Sep 1999
-
-$8.17M(+83.9%)
-$109.34M(-0.1%)
Jun 1999
-
-$50.83M(-2.8%)
-$109.25M(-96.6%)
Mar 1999
-
-$49.45M(-5488.0%)
-$55.56M(-310.3%)
Dec 1998
-
-$885.00K(+89.1%)
-$13.54M(+75.3%)
Sep 1998
-
-$8.09M(-382.4%)
-$54.86M(+49.0%)
Jun 1998
-
$2.86M(+138.5%)
-$107.57M(+29.6%)
Mar 1998
-
-$7.43M(+82.4%)
-$152.84M(+1.5%)
Dec 1997
$9.81M(+118.2%)
-$42.20M(+30.6%)
-$155.20M(+14.6%)
Sep 1997
-
-$60.80M(-43.4%)
-$181.65M(-39.9%)
Jun 1997
-
-$42.40M(-332.7%)
-$129.85M(-71.6%)
Mar 1997
-
-$9.80M(+85.7%)
-$75.65M(+7.8%)
Dec 1996
-$53.81M(-4652.2%)
-$68.65M(-662.8%)
-$82.05M(-45.2%)
Sep 1996
-
-$9.00M(-176.3%)
-$56.51M(+11.2%)
Jun 1996
-
$11.80M(+172.8%)
-$63.61M(+33.5%)
Mar 1996
-
-$16.20M(+62.4%)
-$95.71M(-3.7%)
Dec 1995
$1.18M(-82.6%)
-$43.11M(-167.8%)
-$92.31M(-70.0%)
Sep 1995
-
-$16.10M(+20.7%)
-$54.30M(-108.9%)
Jun 1995
-
-$20.30M(-58.6%)
-$26.00M(-2.4%)
Mar 1995
-
-$12.80M(-151.2%)
-$25.39M(+63.9%)
Dec 1994
$6.79M(+51.3%)
-$5.09M(-141.8%)
-$70.30M(+9.1%)
Sep 1994
-
$12.20M(+161.9%)
-$77.30M(+24.2%)
Jun 1994
-
-$19.70M(+65.9%)
-$102.00M(-49.8%)
Mar 1994
-
-$57.70M(-376.9%)
-$68.10M(-2.1%)
Dec 1993
$4.49M(+295.7%)
-$12.10M(+3.2%)
-$66.70M(+16.1%)
Sep 1993
-
-$12.50M(-188.0%)
-$79.50M(-90.2%)
Jun 1993
-
$14.20M(+125.2%)
-$41.80M(+26.7%)
Mar 1993
-
-$56.30M(-126.1%)
-$57.00M(-138.5%)
Dec 1992
-$2.29M(+94.3%)
-$24.90M(-198.8%)
-$23.90M(+53.5%)
Sep 1992
-
$25.20M(+2620.0%)
-$51.40M(+16.4%)
Jun 1992
-
-$1.00M(+95.7%)
-$61.50M(+16.9%)
Mar 1992
-
-$23.20M(+55.7%)
-$74.00M(-53.2%)
Dec 1991
-$40.09M(-35.9%)
-$52.40M(-447.0%)
-$48.30M(>-9900.0%)
Sep 1991
-
$15.10M(+211.9%)
-$200.00K(+99.0%)
Jun 1991
-
-$13.50M(-640.0%)
-$21.00M(-96.3%)
Mar 1991
-
$2.50M(+158.1%)
-$10.70M(+63.7%)
Dec 1990
-$29.50M(+42.0%)
-$4.30M(+24.6%)
-$29.50M(-17.1%)
Sep 1990
-
-$5.70M(-78.1%)
-$25.20M(-29.2%)
Jun 1990
-
-$3.20M(+80.4%)
-$19.50M(-19.6%)
Mar 1990
-
-$16.30M
-$16.30M
Dec 1989
-$50.90M
-
-

FAQ

  • What is Biogen Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Biogen Inc.?
  • What is Biogen Inc. annual cash from investing year-on-year change?
  • What is Biogen Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Biogen Inc.?
  • What is Biogen Inc. quarterly cash from investing year-on-year change?
  • What is Biogen Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Biogen Inc.?
  • What is Biogen Inc. TTM cash from investing year-on-year change?

What is Biogen Inc. annual cash from investing?

The current annual cash from investing of BIIB is -$799.20M

What is the all-time high annual cash from investing for Biogen Inc.?

Biogen Inc. all-time high annual cash from investing is $1.59B

What is Biogen Inc. annual cash from investing year-on-year change?

Over the past year, BIIB annual cash from investing has changed by +$3.29B (+80.45%)

What is Biogen Inc. quarterly cash from investing?

The current quarterly cash from investing of BIIB is -$35.10M

What is the all-time high quarterly cash from investing for Biogen Inc.?

Biogen Inc. all-time high quarterly cash from investing is $1.68B

What is Biogen Inc. quarterly cash from investing year-on-year change?

Over the past year, BIIB quarterly cash from investing has changed by +$1.15B (+97.03%)

What is Biogen Inc. TTM cash from investing?

The current TTM cash from investing of BIIB is -$158.00M

What is the all-time high TTM cash from investing for Biogen Inc.?

Biogen Inc. all-time high TTM cash from investing is $1.62B

What is Biogen Inc. TTM cash from investing year-on-year change?

Over the past year, BIIB TTM cash from investing has changed by +$1.27B (+88.91%)
On this page